[TLX] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -14,393.18%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 30/09/00 CAGR
Revenue 5,213 3,485 195 0 0 0 0 -
PBT -60,253 -42,815 -15,714 -6,377 -44 -132 -497 26.71%
Tax -15,366 -14,948 -1,884 9 -14 -16 -497 18.44%
NP -44,887 -27,867 -13,830 -6,377 -44 -132 -497 24.88%
Tax Rate - - - - - - - -
Total Cost 50,100 31,352 14,025 6,377 44 132 497 25.56%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 30/09/00 CAGR
NP Margin -861.06 -799.63 -7,087.06 0.00 0.00 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 30/09/00 CAGR
EPS -0.17 -0.12 -0.07 -0.05 0.00 0.00 -0.01 15.00%
EPS Diluted -0.17 -0.12 -0.07 -0.05 0.00 0.00 -0.01 15.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.